Sterling Capital Management’s ACELYRIN SLRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-1,311
Closed -$3.24K 3381
2025
Q1
$3.24K Sell
1,311
-1,028
-44% -$2.44K ﹤0.01% 2376
2024
Q4
$7.34K Buy
2,339
+2,107
+908% +$10.2K ﹤0.01% 2296
2024
Q3
$1.14K Buy
+232
New +$1.2K ﹤0.01% 2458

Other funds holding SLRN

Sterling Capital Management's SLRN Position: Q2 2025 in Review

Sterling Capital Management sold out of ACELYRIN (SLRN) in Q2 2025, closing a stake of 1,311 shares — an estimated $3.24K sold.

Sterling Capital Management first reported a position in SLRN in Q3 2024 and held it in 3 quarters. The position peaked at $7.34K in Q4 2024. 2 funds tracked by Wall St. Rank hold SLRN as of Q2 2025.

  • Sterling Capital Management reported no remaining ACELYRIN position as of Q2 2025 after selling out during the quarter.
  • Sterling Capital Management sold 1,311 ACELYRIN shares in Q2 2025, an estimated $3.24K.
  • Sterling Capital Management first reported a position in ACELYRIN in Q3 2024 and held it in 3 quarters.
  • Sterling Capital Management's ACELYRIN position peaked at $7.34K in Q4 2024.
  • 2 funds tracked by Wall St. Rank held ACELYRIN as of Q2 2025.

Based on Sterling Capital Management's 13F filing for Q2 2025, filed 6 Aug 2025.